Abstract Body

Background: Implementation studies demonstrated that HIV self-testing (ST) is highly acceptable in resource limited settings and could allow savings given its potentially lower implementation cost compared to provider-delivered HIV testing and counselling (HTC). We aimed to evaluate the cost-effectiveness of introduction of ST from 2015 over 20 years in a country such as Zimbabwe. Methodology: The ‘HIV Synthesis’ model was used to simulate an HIV epidemic similar to the one in Zimbabwe. Simulated age and gender specific rates of HTC for the first time, and repeat HTC fitted approximately to those observed; rates incorporated a 3-fold reduction in rate of testing for people who never had condom-less sex and increased rates of HTC for women attending antenatal clinics and for subjects experiencing symptoms. Sensitivity was assumed to be 92% and 98% and specificity 99% and 100%, for ST and HTC respectively. The cost was assumed to be $3 for ST, $9 for HTC if negative and $25 if positive, or following a positive ST. HTC was required for a person to be diagnosed and it was assumed only 80% of those who had a positive ST would be diagnosed within 1 year as a direct result of the ST. Once diagnosed, linkage to care at 1 year was assumed to be 60% and the same reduction in condomless sex (13% with long-term partner and 17% with short-term partners declining to 9% after 6 months) was assumed for people testing positive by HTC or ST. Two main scenarios were considered from 2015. In the reference scenario (RS), ST is not available and the rate of HTC for first time and repeat HTC increases linearly by 0.005 per year. In the intervention scenario (STS), the following effects are assumed: halving of the population not willing to receive a HTC (from 5 to 2.5%), replacing 30% of repeat HTC with ST, replacing 10% of first HTC with ST, and increasing in the rate of repeat testing and of testing for the 1st time by 20%, due to the availability of ST.These assumptions are believed to be conservative in estimating the potential benefits of ST. Results: We predict the introduction of ST could lead to savings in health care costs of $51 million, while averting around 35,000 DALYS over 20 years in Zimbabwe. Table 1 indicates the most cost-effective scenario under different circumstances. Conclusions: These results suggest the introduction of ST is cost-effective under most of these assumptions and should be made available. Further work is needed to gather more data to inform modelling assumptions and allow updated evaluations.